| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 24.65B | 23.89B | 21.88B | 13.86B | 12.79B |
| Gross Profit | 9.71B | 9.86B | 7.54B | 1.60B | 1.50B |
| EBITDA | 7.43B | 6.54B | 7.15B | 1.32B | 1.67B |
| Net Income | 4.95B | 3.05B | 4.08B | -1.81B | -420.00M |
Balance Sheet | |||||
| Total Assets | 64.80B | 62.55B | 63.53B | 61.51B | 63.27B |
| Cash, Cash Equivalents and Short-Term Investments | 15.43B | 11.08B | 9.13B | 5.37B | 7.71B |
| Total Debt | 36.08B | 35.45B | 35.88B | 43.89B | 44.16B |
| Total Liabilities | 51.84B | 50.28B | 51.28B | 52.70B | 52.23B |
| Stockholders Equity | 12.81B | 12.18B | 12.13B | 8.73B | 10.94B |
Cash Flow | |||||
| Free Cash Flow | 7.35B | 6.62B | 6.77B | 511.00M | -333.00M |
| Operating Cash Flow | 8.16B | 7.52B | 7.67B | 1.56B | 1.34B |
| Investing Cash Flow | -1.02B | -2.24B | -1.48B | -522.00M | -1.40B |
| Financing Cash Flow | -4.19B | -5.50B | -3.72B | -1.39B | -1.80B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | HK$125.26B | 20.57 | 42.78% | 3.67% | 5.49% | 9.44% | |
66 Neutral | HK$1.99B | 31.69 | 0.50% | 3.37% | -22.04% | -90.42% | |
66 Neutral | HK$1.94B | 8.75 | 2.64% | 1.95% | -7.90% | 58.19% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
58 Neutral | HK$10.24B | 30.79 | 0.88% | ― | -12.90% | -95.96% | |
55 Neutral | HK$16.29B | 19.30 | 2.12% | 3.05% | -0.04% | -15.56% | |
40 Neutral | HK$476.35M | -0.21 | -29.62% | ― | -0.60% | 34.74% |